LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
© LexDana · beta
LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged chevron deference · clear

Federal Circuit

An Improper Reply to a Final Office Action May Result in the Accrual of Applicant Delay for PTA Calculations

INTRA-CELLULAR THERAPIES, INC v. IANCU Before Wallach, Chen , and Hughes. Appeal from the United States District Court for the Eastern District of Virginia. Summary : If a proper reply to a final Office Action is not filed within the three-month response…

September 18, 2019·Federal Circuit·2 min read
Data: FDA Orange & Purple Books · prosecution & litigation metadata · read-only.